Goldstein Donald I MD is categorized under Ophthalmologists in North Hollywood, CA and active since 1970.
Goldstein Donald I MD was established in 1970, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Donald Goldstein at the company’s single location by writing to 4418 Vineland Avenue # 106, North Hollywood, California CA 91602 or by phoning (818) 762-0647. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Goldstein Donald I MD |
| Contact Person: | Donald Goldstein |
| Address: | 4418 Vineland Avenue # 106, North Hollywood, California 91602 |
| Phone Number: | (818) 762-0647 |
| Website Address: | acvci.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1970 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Ophthalmologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Goldstein Donald I MD was started in 1970 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Donald Goldstein for inquiries that concern Goldstein Donald I MD by calling the company number (818) 762-0647, as your correspondence is most welcome. Additionally, the physical location of the single location of Goldstein Donald I MD can be found at the coordinates 34.15101,-118.37017 as well as the street address 4418 Vineland Avenue # 106 in North Hollywood, California 91602.
For its online presence, you may visit Goldstein Donald I MD’s website at acvci.com and engage with its social media outlets through on Twitter and on Facebook.